NWAM LLC’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-5,564
Closed -$221K 577
2023
Q3
$221K Sell
5,564
-2,557
-31% -$108K 0.02% 454
2023
Q2
$333K Buy
+8,121
New +$335K 0.03% 393
2023
Q1
Sell
-11,962
Closed -$490K 559
2022
Q4
$490K Buy
11,962
+340
+3% +$14.2K 0.04% 314
2022
Q3
$467K Sell
11,622
-271
-2% -$11.6K 0.04% 303
2022
Q2
$500K Buy
11,893
+145
+1% +$6.08K 0.05% 302
2022
Q1
$532K Buy
11,748
+122
+1% +$5.36K 0.04% 318
2021
Q4
$537K Buy
11,626
+769
+7% +$36.4K 0.04% 318
2021
Q3
$515K Sell
10,857
-20
-0.2% -$994 0.05% 317
2021
Q2
$563K Sell
10,877
-5,451
-33% -$274K 0.05% 290
2021
Q1
$822K Sell
16,328
-106
-0.6% -$5.65K 0.08% 229
2020
Q4
$856K Sell
16,434
-82
-0.5% -$3.92K 0.1% 193
2020
Q3
$718K Buy
16,516
+1,165
+8% +$51K 0.12% 147
2020
Q2
$660K Buy
+15,351
New +$634K 0.09% 204
2019
Q4
$718K Buy
15,728
+633
+4% +$25.1K 0.12% 174
2019
Q3
$537K Sell
15,095
-1,909
-11% -$71K 0.1% 194
2019
Q2
$677K Buy
17,004
+749
+5% +$29.5K 0.13% 155
2019
Q1
$676K Buy
+16,255
New +$661K 0.15% 152
2018
Q4
Sell
-4,841
Closed -$235K 362
2018
Q3
$235K Buy
+4,841
New +$229K 0.05% 295

Other funds holding XPH

NWAM LLC's XPH Position: Q4 2023 in Review

NWAM LLC sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q4 2023, closing a stake of 5,564 shares — an estimated $221K sold.

NWAM LLC first reported a position in XPH in Q3 2018 and held it in 18 quarters. The position peaked at $856K in Q4 2020. 73 funds tracked by Wall St. Rank hold XPH as of Q4 2023.

  • NWAM LLC reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q4 2023 after selling out during the quarter.
  • NWAM LLC sold 5,564 State Street SPDR S&P Pharmaceuticals ETF shares in Q4 2023, an estimated $221K.
  • NWAM LLC first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q3 2018 and held it in 18 quarters.
  • NWAM LLC's State Street SPDR S&P Pharmaceuticals ETF position peaked at $856K in Q4 2020.
  • 73 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q4 2023.

Based on NWAM LLC's 13F filing for Q4 2023, filed 14 Feb 2024.